Juvenile Myelomonocytic Leukemia
What's New
Last Posted: Mar 15, 2023
- [Genetic characteristics and survival analysis of 27 cases of juvenile myelomonocytic leukemia].
Li J J, et al. Zhonghua er ke za zhi = Chinese journal of pediatrics 2023 0 (1) 56-60 - Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia.
Stieglitz Elliot, et al. Nature communications 2017 0 (1) 2127 - RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.
Lipka Daniel B, et al. Nature communications 2017 0 (1) 2126 - Human leukocyte antigen disparities reduce relapse after hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A single-center retrospective study from China.
Lin Yu-Chen, et al. Pediatric transplantation 2020 0 (2) e13825 - Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome.
Lasho Terra, et al. Best practice & research. Clinical haematology 2020 0 (2) 101171 - Role of lncRNA Morrbid in PTPN11(Shp2)E76K-driven juvenile myelomonocytic leukemia.
Cai Zhigang, et al. Blood advances 2020 0 (14) 3246-3251 - The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia.
Alfayez Mansour, et al. Leukemia 2020 0 (3) 691-700 - Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor Transplantation.
Rangarajan Hemalatha G, et al. Transplantation and cellular therapy 2021 0 (11) 926.e1-926.e10 - Implications of mosaicism in variant interpretation: A case of a de novo homozygous NF1 variant.
Alghamdi Malak, et al. European journal of medical genetics 2021 0 (7) 104236 - Juvenile xanthogranuloma in Noonan syndrome.
Ali Marwan M, et al. American journal of medical genetics. Part A 2021 0 (10) 3048-3052
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 09, 2023
- Content source: